Corporate Events

Nippon Investment Company proposed to acquire 62.88% stake in CE Holdings Co.,Ltd. (TSE:4320) from NEC Corporation (TSE:6701), Uh Partners 2 Fund L.P., Uh Partners 3 Fund L.P., Hikari Tsushin, Inc. (TSE:9435) and SIL Investment Limited Partnership for ¥17.3 billion on August 5, 2026. Under the terms of the transaction ¥1650 per share is being paid for a cash consideration of ¥17.3 billion. The Board of Directors of CE Holdings Co.,Ltd. formed a special committee for the transaction. The expected completion of the transaction is September 17, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for CE Holdings Co.,Ltd. City-Yuwa Partners acted as legal advisor for CE Holdings Co.,Ltd. Nippon Investment Company completed the acquisition of 45.72% stake in CE Holdings Co.,Ltd. (TSE:4320) from NEC Corporation (TSE:6701), Uh Partners 2 Fund L.P., Uh Partners 3 Fund L.P., Hikari Tsushin, Inc. (TSE:9435) and SIL Investment Limited Partnership for ¥12.6 billion on September 17, 2026.

Cornelis and NEC Corporation announced an expanded collaboration that builds on the companies' successful work together in Europe and will help organizations across Japan and the broader Asia-Pacific region deploy next-generation AI and high-performance computing (HPC) infrastructure using Cornelis high-performance networking solutions. The expanded collaboration builds on NEC's successful evaluation of the Cornelis CN5000 Omni-Path platform and the companies' existing collaboration in Europe, creating a foundation to support enterprise AI, manufacturing, research, and high-performance computing deployments across Japan. As part of the collaboration, NEC also plans to participate in early evaluation activities for the next-generation Cornelis CN6000 platform, helping customers prepare for increasingly complex AI and HPC workloads. The collaboration reflects growing adoption of open, high-performance networking alternatives as AI and HPC deployments continue to scale. Following a comprehensive technical evaluation of the CN5000 platform, NEC and Cornelis will continue collaborating to support customer opportunities by leveraging NEC's long-standing relationships with enterprise, manufacturing, academic, and research organizations throughout Japan. NEC's evaluation included extensive MPI communication testing across multiple workloads and communication patterns, validating the capabilities of the CN5000 platform while also identifying optimization techniques that further improve application performance. The joint evaluation demonstrated the value of close engineering collaboration to help customers maximize networking efficiency across large-scale HPC environments. The companies also plan to extend their collaboration to the upcoming Cornelis CN6000 platform, allowing NEC to evaluate next-generation networking technologies as customers prepare for larger AI training, inference, and HPC deployments. The collaboration further strengthens Cornelis' growing global ecosystem of infrastructure partners, enabling customers to deploy high-performance networking through trusted server and infrastructure providers while benefiting from continued innovation across the Cornelis product portfolio. As AI clusters continue to scale, Cornelis and NEC will continue working together to evaluate new networking technologies, optimize customer deployments, and support future AI and HPC infrastructure across Japan and beyond.

Transgene and NEC Corporation reported sustained 100% three-year disease-free survival (DFS) in patients treated with TG4050 in the Phase 1 part of a randomized Phase 1/2 trial evaluating TG4050, the first individualized neoantigen therapeutic vaccine (INTV) based on the myvac platform, in patients with resected, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC). The companies also announced the publication of the Phase 1 comprehensive clinical and translational data from the study, for the first time in the peer-reviewed journal Nature Communications. Three-year follow-up data from the Phase 1 trial continue to demonstrate durable clinical outcomes in the adjuvant setting, with all 16 TG4050-treated patients remaining disease-free while three of 16 patients in the control arm experienced relapse after a median follow-up of 41 months. TG4050, encoding up to 30 patient-specific neoantigens, also continues to demonstrate a favorable safety profile with no unexpected safety findings. The peer-reviewed publication builds on the Phase 1 results first shared with the scientific community through a prepublication on medRxiv and presents comprehensive clinical and translational findings based on the study’s primary data cut-off, including detailed analyses of vaccine-induced immune responses. Together, the clinical and translational findings provide further evidence supporting TG4050 as a potential individualized immunotherapy for patients with head and neck cancer at high risk of relapse following surgery and (chemo)-radiotherapy. The Phase 1 clinical and translational data published in Nature Communications demonstrate robust and persistent neoantigen-specific CD8+ T-cell responses consistent with the proposed vaccine’s mechanism of action. Vaccine-induced responses were detected in 73.3% of patients treated with TG4050, with a median of three responding neoantigens per responder. These responses were maintained throughout treatment and persisted for more than one year after the last vaccination, providing evidence of durable anti-tumor immunity. Robust and persistent CD8+ T-cell responses against patient-specific tumor neoantigens were observed following TG4050 vaccination, supporting the vaccine’s ability to generate a targeted anti-tumor immune response. TG4050 continues to be evaluated in the ongoing randomized Phase 1/2 clinical trial (NCT04183166) in patients with resected HNSCC. Key upcoming milestones include first immunological data and two-year efficacy data (DFS) from the Phase 2 study respectively in H2 2026 and First Quarter 2028. TG4050 is an individualized immunotherapy being developed for solid tumors that is based on Transgene’s myvac technology and powered by NEC’s longstanding artificial intelligence (AI) and machine learning (ML) expertise. This virus-based individualized neoantigen therapeutic vaccine (INTV) encodes neoantigens (patient-specific mutations) identified and selected by NEC’s Neoantigen Prediction System. The prediction system is based on more than two decades of expertise in AI and has been trained on proprietary data allowing it to accurately prioritize and select the most immunogenic sequences. TG4050 is designed to stimulate the immune system of patients in order to induce a T-cell response that is able to recognize and destroy tumor cells based on their own neoantigens. This individualized immunotherapy is developed and produced for each patient. TG4050 is being evaluated in a Phase 1/2 clinical trial for patients with HPV-negative head and neck cancers (NCT04183166). An individualized treatment is created for each patient after they complete surgery and while they receive adjuvant therapy. Half of the participants received their vaccine immediately after completing adjuvant treatment. The other half were given TG4050 at the time of recurrence of the disease as an additional treatment to the standard of care (SoC). This randomized study is evaluating the treatment benefits of TG4050 in patients who are at risk of relapse. The first efficacy data (2-year disease-free survival – DFS) will become available at the latest by the end of First Quarter 2028.

Assist Group Srl along with other buyers entered into an agreement to acquire Overseas network equipment resale business from NEC Corporation (TSE:6701) on August 5, 2026. Overseas network equipment resale business involves building systems for overseas telecommunications operators and enterprises using network equipment from partner companies, as well as its IT services business for governments and local authorities in certain countries, which includes system development for biometric authentication and smart cities. The overseas network equipment resale business operates in regions such as Latin America, the Asia-Pacific, and Europe, and upon the conclusion of this agreement, the entire business will be transferred. In addition, the IT services business for government and local authorities in certain countries will be transferred, including parts of business in Latin America and Europe, where operations are primarily centered on the overseas network equipment resale business. Until the completion of the transfer, NEC Corporation will continue to operate these businesses as usual and will work closely with partner companies to ensure a smooth transition. Furthermore, NEC Corporation will continue to supply biometric authentication-related products in the countries where the IT services business for government and local authorities is being transferred, even after the transfer is complete. The transfer is expected to be completed during fiscal year 2026 subject to customary closing conditions.

NEC Corporation revised consolidated earnings guidance for the fiscal year ending March 31, 2027. For the period, the company expects revenue of JPY 3,540,000 million.

NEC Corporation, ¥ 20.0, Cash Dividend, Sep-29-2026

Noetra Corp. announced that it has received a round of fudning on July 16, 2026. The transaction included participation from new investors, Sony Group Corporation, SoftBank Corp., NEC Corporation, Honda Motor Co., Ltd. The company has issed convertibe prefrerred stock in the trasna

NEC Corporation has completed a Fixed-Income Offering in the amount of ¥20 billion. Security Name: 1.884% Straight Bonds due June 15, 2029 Security Type: Corporate Bond/Note (Non Convertible) Principal Amount: ¥20 billion Price\Range: 100% Security Features: Unsecured Coupon Type: Fixed

NEC Corporation, Q1 2027 Earnings Call, Jul 29, 2026

NEC Corporation announced that they will report Q1, 2027 results on Jul 29, 2026

NEC Corporation has completed a Fixed-Income Offering in the amount of ¥30 billion. Security Name: 2.319% Straight Bonds due June 17, 2031 Security Type: Corporate Bond/Note (Non Convertible) Principal Amount: ¥30 billion Price\Range: 100% Security Features: Unsecured Coupon Type: Fixed

NEC Corporation has announced a Fixed-Income Offering. Security Name: Straight Bonds due June 17, 2031 Security Type: Corporate Bond/Note (Non Convertible) Principal Amount: ¥30 billion Security Features: Unsecured

NEC Corporation has announced a Fixed-Income Offering. Security Name: Straight Bonds due June 15, 2029 Security Type: Corporate Bond/Note (Non Convertible) Principal Amount: ¥20 billion Security Features: Unsecured

Intermedia Intelligent Communications announced the general availability of Cloud Calling for UNIVERGE BLUE, a new cloud voice service that directly connects KDDI’s voice with NEC’s UNIVERGE BLUE, powered by Intermedia. This solution enables organizations to use KDDI-provided telephone numbers across multiple locations nationwide in Japan without installing customer-premises voice equipment. Connectivity to Cloud Calling for UNIVERGE BLUE is the result of coordinated work across three organizations: KDDI and NEC define the commercial service offering, while KDDI and Intermedia establish cloud PBX interconnection to KDDI’s voice services. Together, these three companies align on operational and support terms to deliver a seamless customer experience. The integration allows organizations using UNIVERGE BLUE CONNECT to activate and manage KDDI-provided telephone numbers directly within Intermedia’s cloud platform through a dedicated peering connection – making nationwide, multi-site deployments far simpler to implement and operate. By providing nationwide carrier connectivity through KDDI, Cloud Calling removes a key constraint that previously limited full-cloud communications deployments across Japan, now making large-scale migration from legacy PBX systems to cloud platforms far more practical. In Japan, Intermedia works with NEC and its partners to deliver UNIVERGE BLUE CONNECT. NEC’s installed base includes millions of on-premises PBX seats across Japan, representing one of the largest opportunities for business communications migration to the cloud in the Japanese market. UNIVERGE BLUE CONNECT combines business phone, video meetings, messaging, collaboration tools and contact center capabilities with integrated archiving and AI-powered tools that generate conversation transcripts and summaries, surface opportunity insights and provide real-time assistance. Through Cloud Calling with KDDI, organizations can deploy UNIVERGE BLUE CONNECT across multiple locations nationwide while using KDDI-provided telephone numbers, supporting full-cloud communications environments that were previously difficult to achieve. Intermedia’s platform also allows organizations to extend these capabilities into Microsoft Teams, giving businesses the ability to add enterprise-grade voice capabilities and compliant archiving directly within the Teams environment while supporting both Microsoft Teams-based calling and UNIVERGE BLUE CONNECT deployments powered by Intermedia. Cloud Calling for UNIVERGE BLUE connects the strengths of three organizations: NEC and its partners sell UNIVERGE BLUE CONNECT cloud communications licenses powered by Intermedia; KDDI provides telephone numbers and calling services directly to customers; Intermedia activates and manages those numbers within its cloud platform through a dedicated peering connection. This structure allows organizations to deploy cloud communications across multiple locations nationwide while keeping numbering and voice services with a domestic carrier. With nationwide carrier connectivity now available through KDDI, organizations have a clearer path to transition from legacy PBX systems to modern cloud communications platforms while continuing to work with NEC and its partners.

Aviat Networks, Inc. has withdrawn its Shelf Registration dated June 13, 2025 in the amount of $16.893678 million. Security Name: Common Stock Securities Offered: 736,750

NEC Corporation - Special Call

NEC Corporation announced that its Board of Directors decided upon the dividends to be paid to shareholders based on the record date of March 31, 2026. For the year ended March 31, 2026, the company announced a dividend of JPY 22 per share as compared to JPY 70 per share in the previous year. Effective Date is June 1, 2026. NEC conducted a share split at a ratio of five (5) shares for one (1) share of its common shares, effective April 1, 2025.

NEC Corporation resolved at the meeting of its Board of Directors held on May 12, 2026, to propose a partial amendment to the Articles of Incorporation at the 188th Ordinary General Meeting of Shareholders to be held on June 19, 2026, as follows. Reason for the amendment: With the enforcement of the "Act for Partially Amending the Act on Strengthening Industrial Competitiveness and Other Related Acts" (Act No. 70 of 2021), listed companies are allowed to hold a general meeting of shareholders without a designated location (a "virtual-only general meeting of shareholders") by stipulating so in their articles of incorporation. In light of the occurrence of large-scale disasters, including infectious diseases and natural disasters, as well as the progress of digitization of society, NEC believes that expanding the options for holding general meetings of shareholders and creating an environment in which more shareholders can easily attend general meetings of shareholders will benefit its shareholders. Therefore, NEC proposes to add Article 12, Paragraph 3, to the current Articles of Incorporation to allow general meetings of shareholders to be held without a designated location. The Board of Directors will carefully consider the social conditions and the circumstances surrounding NEC and its shareholders, as well as securing the rights and interests of shareholders when deciding on the format of each general meeting of shareholders. NEC has received confirmation from the Minister of Economy, Trade and Industry and the Minister of Justice that the requirements specified by the Ordinance of the Ministry of Economy, Trade and Industry and the Ordinance of the Ministry of Justice regarding the amendment are met.

Ordinary General Meeting of Shareholders

NEC Corporation, Board Meeting, May 12, 2026. Agenda: To consider a partial amendment to the Articles of Incorporation at the 188th Ordinary General Meeting of Shareholders to be held on June 19, 2026.

NEC Corporation provided year-end dividend guidance for the fiscal year ending March 31, 2027. For the period, the company expects to pay year end dividend of JPY 20.00 per share as compared to JPY 22.00 per share paid a year ago.

NEC Corporation provided second quarter end dividend guidance for the fiscal year ending March 31, 2027. For the period, the company expects to pay year end dividend of JPY 20.00 per share as compared to JPY 16.00 per share paid a year ago.

NEC Corporation provided consolidated earnings guidance for the fiscal year ending March 31, 2027. For the period, the company expects revenue of JPY 3,500,000 million.

NEC Corporation expected to report Q1 2027 results on July 28, 2026. This event was calculated by S&P Global (Created on April 30, 2026).

NEC Corporation reported earnings results for the full year ended March 31, 2026. For the full year, the company reported sales was JPY 3,582,733 million compared to JPY 3,423,431 million a year ago. Net income was JPY 270,228 million compared to JPY 175,183 million a year ago. Basic earnings per share from continuing operations was JPY 202.95 compared to JPY 131.5 a year ago. Diluted earnings per share from continuing operations was JPY 202.95 compared to JPY 131.49 a year ago.

NEC Corporation, Annual General Meeting, Jun 19, 2026, at 10:00 Tokyo Standard Time. Location: NEC Tamagawa Renaissance City Hall, Tamagawa Plant, NEC Corporation 1753 Shimonumabe, Nakahara-ku, Kawasaki, Kanagawa Nakahara-ku Kanagawa Japan Agenda: To consider the business report, the consolidated financial statements and the non-consolidated financial statements of the 188th business period from April 1, 2025 to march 31, 2026, and consider the results of the audit on the consolidated financial statements conducted by the accounting auditors and the audit committee; to consider partial amendment to the articles of incorporation; and to consider election of ten directors.

Mid-term Management Plan Briefing

NEC Corporation, 2026 Earnings Call, Apr 28, 2026

NEC Corporation Presents at 2026 Japan-Texas Economic Summit, May-11-2026 . Venue: Live! by Loews, Arlington, Texas, United States. Speakers: Toshifumi Yoshizaki, Executive Officer, Corporate Senior EVP & COO.

U.S.-Japan Council, 2026 Japan-Texas Economic Summit, May 11, 2026 through May 13, 2026. Venue: Live! by Loews, Arlington, Texas, United States. Programming will focus on major drivers of Japan-Texas engagement, including cross-border capital flows, AI infrastructure and data center expansion, energy security and power generation, and strategic growth sectors such as semiconductors, space, real estate development, food and beverage, sports and entertainment, and workforce development.

NEC Corporation announced that they will report fiscal year 2026 results on Apr 28, 2026

Transgene and NEC Bio B.V. (“NEC”), a wholly owned subsidiary of NEC Corporation, announce the signing of a license agreement to advance the clinical development of TG4050, an individualized neoantigen therapeutic vaccine (INTV) in the adjuvant treatment of resected HPV-negative head and neck cancer. Under the terms of the license agreement, Transgene secures access to NEC’s AI-based neoantigen prediction platform for further development of TG4050 in the adjuvant treatment of resected HPV-negative head and neck cancer while conferring rights to enable Transgene’s further clinical development and to support commercialization and potential partnering of the program. NEC retains full ownership and operational control of its AI platform and will support Transgene to conduct further clinical activity. NEC will receive a technology access fee of EUR 2.5 million in Transgene shares following the signing and an additional EUR 2.5 million in cash to be paid out in a series of tranches through early 2028. Additionally, a further payment will be milestone-based and a portion of such payment will be made in Transgene’ shares. NEC is also eligible to receive undisclosed additional consideration including development milestone payments, as well as a double-digit share of profits or licensing revenues. A EUR 2.5 million portion of the access fee to be paid to NEC will be paid in Transgene shares. Transgene will thus issue 3,345,824 new shares to NEC Bio B.V. at a price of EUR 0.7472 per share. This price corresponds to the volume-weighted average (VWAP) of last five (5) closing prices of the Transgene shares on the regulated market of Euronext in Paris prior to signing. The new shares will represent 1.22% of the share capital of Transgene post issuance (and 0.98% of its voting rights). The capital increase is carried out on the basis of the 22nd resolution of the Combined General Meeting of May 15, 2025. The new shares will be admitted to trading on the regulated market of Euronext in Paris as soon as they are issued and will be immediately assimilated to the existing Transgene shares (ISIN code FR0005175080). The capital increase is expected to be completed by the end of April 2026.

NEC Corporation Presents at Humanoids Summit, May-28-2026 . Venue: Takanawa Gateway Convention Center, Tokyo, Japan.

ALM Ventures, Humanoids Summit, May 28, 2026 through May 29, 2026. Venue: Takanawa Gateway Convention Center, Tokyo, Japan.

DigitalBridge Group, Inc. (NYSE:DBRG) and Japan Extensive Infrastructure, Limited acquired Selected Data Center Assets from NEC Corporation from NEC Corporation (TSE:6701) on March 31, 2026. Following the transaction, the acquired assets will be operated as a new standalone platform. NEC Corporation will remain as the anchor customer, providing stable, contracted demand. DigitalBridge Group, Inc. (NYSE:DBRG) and Japan Extensive Infrastructure, Limited completed the acquisition of Selected Data Center Assets from NEC Corporation from NEC Corporation (TSE:6701) on March 31, 2026.

From February 9, 2026 to March 24, 2026, the company has repurchased 6,800,000 shares, representing 0.51% for ¥27,292.83 million. With this, the company has completed the repurchase of 6,800,000 shares, representing 0.51% for ¥27,292.83 million under the buyback announced on February 9, 2026.

The company closed its plan on March 24, 2026.

NEC Corporation Presents at Optical Fiber Communication Conference 2026, Mar-15-2026 . Venue: Los Angeles Convention Center, JW Marriott Los Angeles L.A. LIVE, Los Angeles, California, United States. Speakers: Hitoshi Takeshita.

Rapidus Corporation announced that it has raised ¥267.6 billion in a round of funding on February 27, 2026. The transaction include participation from new investors Dai Nippon Printing Co., Ltd., ARGO GRAPHICS Inc., Canon Inc., Development Bank of Japan Inc., Investment Arm, Fujifilm Corporation, Fujitsu Limited, Furukawa Electric Co., Ltd., Hokkaido Electric Power Company, Incorporated, Honda Motor Co., Ltd., IBM Japan, Ltd., JX Advanced Metals Corporation, Kyocera Corporation, Mizuho Bank, Ltd., Investment Arm, Nagase & Co., Ltd., Nippon Express Co. Ltd., Nohmi Bosai Ltd., North Pacific Bank, Ltd., Investment Arm, Seiko Epson Corporation, Sumitomo Mitsui Banking Corp., Investment Arm, The Chiba Bank Ltd., Investment Arm, The Higo Bank, Ltd, Investment Arm, The Hokkaido Bank, Ltd., Investment Arm, The Hokuriku Bank, Ltd, Investment Arm, Ushio Inc. and Information-Technology Promotion Agency; and returning investors, DENSO Corporation; KIOXIA Corporation, MUFG Bank, Ltd., Investment Arm, NEC Corporation, NTT, Inc., SoftBank Corp., Sony Group Corporation and Toyota Motor Corporation. Information-Technology Promotion Agency invested ¥100 billion. The company has issued convertible preferred stock in the transaction.

NEC Corporation (TSE:6701) announces a share repurchase program. Under the program, the company will repurchase up to 6,800,000 shares, representing 0.51% of its issued share capital (excluding treasury stock), for a total purchase price of ¥30,000 million. The purpose of the program is return profits to shareholders, to enhance shareholder value and to improve company's financial condition. The program will continue through March 31, 2026. As of January 31, 2026, the company had 1,335,299,289 issued shares (excluding treasury stock) and 18,324 treasury shares.

The Board of Directors of NEC Corporation has authorized a buyback plan on February 9, 2026.

NEC Corporation, Board Meeting, Feb 09, 2026. Agenda: To consider the Notice Regarding Repurchase of Shares of Common Stock.

NEC Corporation reported earnings results for the nine months ended December 31, 2025. For the nine months, the company reported sales was JPY 2,422,317 million compared to JPY 2,321,809 million a year ago. Net income was JPY 142,278 million compared to JPY 71,554 million a year ago. Basic earnings per share from continuing operations was JPY 106.74 compared to JPY 53.7 a year ago. Diluted earnings per share from continuing operations was JPY 106.74 compared to JPY 53.7 a year ago.

NEC Corporation revised consolidated earnings guidance for the year ending March 31, 2026. For the period, the company expects revenue of JPY 3,560,000 million.

NEC Corporation, Board Meeting, Jan 29, 2026. Agenda: To consider and decide on appointments for Representative Executive Officers and Executive Officers effective as of April 1, 2026.

NEC Corporation, Q3 2026 Earnings Call, Jan 29, 2026

NEC Corporation announced that they will report Q3, 2026 results on Jan 29, 2026

NEC Corporation expected to report Fiscal Year 2026 results on April 28, 2026. This event was calculated by S&P Global (Created on April 16, 2026).

To briefing on NEC Innovation Day

PopID, Inc. announced that it has raised a round of funding on December 3, 2025. The company issued convertible preferred stock in the transaction. The transaction included participation from new investor NEC Corporation.

Netcracker Technology and NEC Corporation announced that KDDI will deploy Netcracker Digital Commerce & Monetization, part of the Netcracker Digital Platform, as the foundation of its long-term BSS strategy. With support from its parent company, NEC, which will serve as the prime system integrator on the project, Netcracker will deploy its Active Mediation to help KDDI optimize and streamline operations through improved resource utilization and the ability to perform in-house development while assuring the continuation of high-quality services for end customers. With the next-generation mediation solution, KDDI will be able to improve development, operations and troubleshooting through the new system's configurability and flexibility, resulting in better self-sufficiency and control.

Broadcom Inc. announced plans to expand its strategic partnership with NEC Corporation to adopt a modern private cloud utilizing VMware Cloud Foundation (VCF). Leveraging the skills and expertise gained from implementing VCF in its own IT systems, NEC will promote the modernization of private clouds, enabling customers to ensure security and accelerate innovation. VCF is the first integrated cloud platform designed to enable a modern private cloud, combining the flexibility and agility of public cloud environments with the security, performance, and low total cost of ownership (TCO) offered by private clouds. VCF enables consistent operation and management of all applications--traditional, modern, or AI-driven--on a single platform. VCF gives customers a unified private cloud platform that simplifies deployment and operations while strengthening security and lowering risk and cost. Currently, nine of the top 10 Fortune 500 companies deploy VCF. As a partner, NEC offers VCF-based solutions to customers as part of its value creation model--NEC BluStellar Scenario. NEC also offers VCF as a managed service as of October 2025. NEC Private Cloud Infrastructure powered by VMware is a new service that utilizes VCF to provide customers with flexible resources for building hybrid cloud environments and supporting the development of highly adaptable cloud solutions.

NEC Corporation - Analyst/Investor Day

NEC Corporation Presents at 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2025), Nov-04-2025 . Venue: National Harbor, Maryland, United States.

NEC Corporation Presents at Super Terminal Expo (STE) 2025, Nov-04-2025 . Venue: AsiaWorld-Expo, Hong Kong.

Kyocera Corporation (TSE:6971) signed a letter of intent to acquire 33% stake in Japan Aviation Electronics Industry, Limited (TSE:6807) from NEC Corporation (TSE:6701) on August 31, 2025. Under the Share Transfer to be implemented pursuant to the share transfer agreement executed with NEC as of October 30, 2025, KYOCERA shall obtain 22,232,269 Company shares The expected completion of the transaction is October 31, 2025.

NEC Corporation, ¥ 16.0, Cash Dividend, Mar-30-2026

NEC to Acquire CSG, Strengthening Its Position as a Global Leader in Digital Transformation

NEC Corporation expected to report Q3 2026 results on January 30, 2026. This event was calculated by S&P Global (Created on January 21, 2026).

NEC Corporation provided consolidated earnings guidance for the year ending March 31, 2026. For the year, the company expects revenue to be JPY 3,420,000 million.

NEC Corporation announced dividend of JPY 16.00 per share for the end of second quarter of year ending March 31, 2026. Scheduled date of dividend payments is December 1, 2025.

NEC Corporation, Board Meeting, Oct 29, 2025. Agenda: To consider and resolve to acquire CSG Systems International, Inc. through its wholly owned North American subsidiary, NEC Corporation of America and the Company has executed a merger agreement providing for the Transaction with CSG.

NEC Corporation (TSE:6701) entered into a definitive agreement to acquire CSG Systems International, Inc. (NasdaqGS:CSGS) for $2.3 billion on October 29, 2025. NEC will acquire CSG for $80.70 per share in cash, for a total enterprise value of approximately $2.9 billion, or approximately ¥440 billion, including debt. The transaction price represents a 17.38% premium over CSG’s closing price of $68.75 on October 28, 2025, and a 23.07% premium to the volume-weighted average price (VWAP) of CSG common stock for the 30 days ending October 28, 2025. The transaction is expected to close within the 2026 calendar year, subject to the satisfaction of customary closing conditions, including approval by CSG shareholders and receipt of required regulatory approvals. The agreement has been unanimously approved by both companies' boards. Goldman Sachs is serving as financial advisor, Freshfields is serving as legal advisor, and FGS Global is serving as strategic communications advisor to NEC. Jefferies is serving as financial advisor, Simpson Thacher & Bartlett LLP is serving as legal advisor, and Joele Frank, Wilkinson Brimmer Katcher is serving as strategic communications advisor to CSG.

IEEE Communications Society, IEEE Photonics Society, The Optical Society Of America, Incorporated, Optical Fiber Communication Conference, Optical Fiber Communication Conference 2026, Mar 15, 2026 through Mar 19, 2026. Venue: Los Angeles Convention Center, JW Marriott Los Angeles L.A. LIVE, Los Angeles, California, United States.

NEC Corporation, Q2 2026 Earnings Call, Oct 29, 2025